Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Adjuvant TACE in Radical Surgery for Hepatocellular Carcinoma With High-risk Recurrence Factors: A Phase III Randomized Controlled Clinical Study

NCT07417397 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT07417397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07417397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Adjuvant TACE in Radical Surgery for Hepatocellular Carcinoma With High-risk Recurrence Factors: A Phase III Randomized Controlled Clinical Study
Lead sponsor
Guangxi Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2026
Completion date
December 31, 2029
Enrollment
442 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant, hepatocellular carcinoma, transarterial chemoembolization